Heterologous challenge with porcine reproductive and respiratory syndrome (PRRS) vaccine virus: no evidence of reactivation of previous European-typePRRS virus infection

Citation
A. Botner et al., Heterologous challenge with porcine reproductive and respiratory syndrome (PRRS) vaccine virus: no evidence of reactivation of previous European-typePRRS virus infection, VET MICROB, 68(3-4), 1999, pp. 187-195
Citations number
17
Categorie Soggetti
Veterinary Medicine/Animal Health",Microbiology
Journal title
VETERINARY MICROBIOLOGY
ISSN journal
03781135 → ACNP
Volume
68
Issue
3-4
Year of publication
1999
Pages
187 - 195
Database
ISI
SICI code
0378-1135(19990831)68:3-4<187:HCWPRA>2.0.ZU;2-4
Abstract
In Denmark, a porcine reproductive and respiratory syndrome virus (PRRSV) c ontrol programme, comprising vaccination of seropositive herds with a live American type PRRSV vaccine, was started in 1996. In several of these herds , spread of vaccine virus from vaccinated 3-18 week old pigs to non-vaccina ted sows was demonstrated by the isolation of vaccine virus from fetuses an d stillborn piglets. Surprisingly, sows infected with the American type vac cine strain consistently exhibited significantly stronger serological respo nses towards European type PRRSV than American type PRRSV. Tn order to eluc idate whether the unexpectedly strong serological reaction towards European -type PRRSV in American type PRRSV infected sows was due to a booster react ion, or reactivation of an unrecognized, latent infection in the sows with European type PRRSV, a challenge study with the vaccine was carried out. In this study, the stronger serological response towards European type PRRSV than towards American type PRRSV was reproduced, and reactivation of the pr evious natural infection with European PRRSV could neither be demonstrated by virus isolation nor by RT-PCR. So, the increase in antibody titers towar ds European PRRSV in previously European PRRSV infected pigs after challeng e with the vaccine strain seems to be the result of a boosting effect on th e immune system, induced by the heterologous vaccine PRRSV strain. (C) 1999 Elsevier Science B.V. All rights reserved.